We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Tomography May Improve Breast Cancer Risk Assessment

By MedImaging International staff writers
Posted on 25 Mar 2020
Print article
Image: The SoftVue 3D whole breast ultrasound system (Photo courtesy of DMT)
Image: The SoftVue 3D whole breast ultrasound system (Photo courtesy of DMT)
A new study suggests that tissue sound speed, as derived from ultrasound tomography (UST) is a potential surrogate marker of breast density.

Researchers at the U.S. National Cancer Institute (NCI, Rockville, MD, USA), the Mayo Clinic (Rochester, MN, USA), George Washington University (GW; Washington, DC, USA), and other institutions conducted a case-control study to evaluate the relationship of sound speed and mammographic percent density (MPD) with breast cancer risk. The study compared 61 patients with a recent breast cancer diagnosis with 165 women with no history of breast cancer. The researchers used the Delphinus Medical Technologies (DMT; Novi, MI, USA) SoftVue 3D whole breast ultrasound system.

The results showed that increasing quartiles of whole breast volume-averaged sound speed were consistently, and more strongly, associated with increasing breast cancer risk than quartiles of mammographic percent density. According to the researchers, the findings are statistically significant, and suggest future opportunities for utilizing UST-breast cancer risk assessment, particularly in younger women with the absence of ionizing radiation. The study was published on January 29, 2020, in the Journal of Clinical Medicine.

“It is well-established that dense breast tissue is a breast cancer risk factor. Whole breast ultrasound tomography may provide stronger and more specific information about that risk than mammography, which may ultimately help to stratify the risk in order to suggest more personalized screening and interventions,” said study co-author Rachel Brem, MD, of GW. “We are encouraged by the study results that indicate the potential use of whole breast ultrasound to improve the accuracy of breast cancer risk assessment with a non-ionizing breast imaging modality.”

Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.

Related Links:
U.S. National Cancer Institute
Mayo Clinic
George Washington University
Delphinus Medical Technologies


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Advanced Cardiac MRI Analysis Software
3Di Cardiac MR
Under Table Shield
3 Section Double Pivot Under Table Shield
New
Oncology Information System
RayCare

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.